UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048732
Receipt number R000055522
Scientific Title Guided Internet-based Cognitive Behavioral Therapy for Bulimia Nervosa: A Multi-Institutional Randomized Controlled Trial
Date of disclosure of the study information 2022/08/23
Last modified on 2023/01/22 15:03:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Guided Internet-based Cognitive Behavioral Therapy for Bulimia Nervosa: A Multi-Institutional Randomized Controlled Trial

Acronym

Guided ICBT for BN: MRCT

Scientific Title

Guided Internet-based Cognitive Behavioral Therapy for Bulimia Nervosa: A Multi-Institutional Randomized Controlled Trial

Scientific Title:Acronym

Guided ICBT for BN: MRCT

Region

Japan Europe


Condition

Condition

Bulimia nervosa

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To Evaluate the efficacy and safety of Guided Internet based cognitive behavioral therapy for patients with bulimia nervosa

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change in the frequency of weekly objective binge-eating and vomiting episodes between the pre and post-treatment

Key secondary outcomes

Change pre and post treatment and changes at 1 month, 3 months, 6 months, 9 months, and 21 months after the end of treatment

EDE-Q: Eating Disorder Examination Questionnaire
PHQ-9: Patient Health Questionnaire-9
GAD-7: Generalized Anxiety Disorder -7
EQ-5D-5L: The 5-level EuroQol 5 dimension
BMI: Body Mass Index
BBQ: The Brunnsviken Brief Quality of life scale
PSQI: Pittsburgh Sleep Quality Index
WAI-SF: Working Alliance Inventory
CSQ: Client Satisfaction Questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

Guided internet cognitive behavioral therapy

Interventions/Control_2

Treatment as usual

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

13 years-old <=

Age-upper limit

65 years-old >=

Gender

Female

Key inclusion criteria

1. Meets the DSM-5 diagnostic criteria for bulimia nervosa.
2. Patients with a BMI of 17.5 or higher.
3. Woman aged between 13 and 65 years old at the time of obtaining informed consent.
4. Written or electronic informed consent has been obtained.
5. Patients who are receiving usual treatment, and no new drug therapy or additional changes are planned during the study period.
6. Patients who owns a personal computer, tablet, smartphone, etc., or the guardian of the research subject who is not an adult owns the above devices, and the research subject himself/herself practically uses them on a daily basis.
7. Patients who have an internet communication environment and has the minimum necessary ICT skills.
8. Not received cognitive behavioral therapy in the last 2 years.

Key exclusion criteria

1. Patients who have serious mental disorders such as organic brain disorders, psychotic disorders, and drug dependence.
2. Patients who are at imminent risk of suicide.
3. Patients who repeatedly engage in anti-social behavior.
4. Patients who have a serious progressive physical disease.
5. Patients who have difficulty in exposure to feared objects due to severe stress reactions or dissociation symptoms due to acute stress disorder or post-traumatic stress disorder.
6. Patients who are judged inappropriate by the principal investigator or the research co-investigator to conduct this research safely.

Target sample size

54


Research contact person

Name of lead principal investigator

1st name Yoshifumi
Middle name
Last name Mizuno

Organization

University of Fukui

Division name

Research Center for Child Mental Development.

Zip code

9101193

Address

23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan

TEL

0776-61-8707

Email

mizunoy@u-fukui.ac.jp


Public contact

Name of contact person

1st name Sayo
Middle name
Last name Hamatani

Organization

University of Fukui

Division name

Research Center for Child Mental Development

Zip code

9101193

Address

23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan

TEL

0776-61-8707

Homepage URL

https://www.iterapi.se/sites/jzenit/

Email

sayoh@u-fukui.ac.jp


Sponsor or person

Institute

University of Fukui

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tohoku University Hospital
University of Chiba
Dokkyo Medical University Saitama Medical Center
National Center of Neurology and Psychiatry
University of Tokushima
University of Kagoshima
Linkoping University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Research Ethics Committee of University of Fukui

Address

23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan

Tel

0776-61-8529

Email

chiken@ml.u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福井大学(福井県)、東北大学病院(宮城県)、千葉大学(千葉県)、獨協医科大学埼玉医療センター(埼玉県)、国立精神神経医療研究センター(東京)、徳島大学(徳島県)、鹿児島大学(鹿児島県)、Linkoping Univeristy


Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 06 Month 22 Day

Date of IRB

2022 Year 08 Month 15 Day

Anticipated trial start date

2022 Year 08 Month 24 Day

Last follow-up date

2026 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 08 Month 23 Day

Last modified on

2023 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055522


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name